Metlife, Inc. (MET) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts MET Hot Sheet
Price: $96.78 +1.14%
EPS Growth %: +9.4%
Financial Fact:
Net derivative gains (losses): -1.05B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +9.4%
Financial Fact:
Net derivative gains (losses): -1.05B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Metlife, Inc. (NYSE: MET) reported Q2 EPS of $1.39, $0.02 worse than the analyst estimate of $1.41.
For earnings history and earnings-related data on Metlife, Inc. (MET) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Copart to buy ACV for $1.9 billion in cash deal
- Cosciens acquires Nualtis for up to $15M in cash deal
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
